Bactericidal and cross-protective activities of a monoclonal antibody directed against Neisseria meningitidis NspA outer membrane protein

被引:36
作者
Cadieux, N
Plante, M
Rioux, CR
Hamel, J
Brodeur, BR
Martin, D
机构
[1] Ctr Hosp Univ Quebec, Unite Rech Vaccinol, St Foy, PQ G1V 4G2, Canada
[2] Univ Laval, St Foy, PQ G1V 4G2, Canada
关键词
D O I
10.1128/IAI.67.9.4955-4959.1999
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The cross-bactericidal and cross-protective activities of a monoclonal antibody (MAb) named Me-7, which is directed against an antigenically highly conserved epitope on the meningococcal NspA protein, were studied, This MAb efficiently killed in vitro, in the presence of rabbit or human serum, 13 of 14 meningococcal strains tested, including 9 of 9, 2 of 3, and 2 of 2 strains of serotypes B, A, and C, respectively, MAb Me-7 also significantly reduced by more than 75% the levels of bacteremia recorded for mice challenged with 10 of 11 meningococcal strains tested. Analysis of the predicted amino acid sequence of the NspA protein from the meningococcal strain MCH88 (A:4:P1.10), which was not killed by MAb Me-7, indicated the presence of an additional glutamine residue at position 73, compared to the three other NspA sequences, The data presented in this study suggest that antibodies directed against this highly conserved outer membrane protein could protect against meningococcal infections.
引用
收藏
页码:4955 / 4959
页数:5
相关论文
共 23 条
[1]   The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains [J].
AlaAldeen, DAA ;
Borriello, SP .
VACCINE, 1996, 14 (01) :49-53
[2]   PROTECTIVE EFFICACY OF MOUSE SERUM TO THE N-PROPIONYL DERIVATIVE OF MENINGOCOCCAL GROUP-B POLYSACCHARIDE [J].
ASHTON, FE ;
RYAN, JA ;
MICHON, F ;
JENNINGS, HJ .
MICROBIAL PATHOGENESIS, 1989, 6 (06) :455-458
[3]   PROTECTION AGAINST INFECTION WITH NEISSERIA-MENINGITIDIS GROUP-B SEROTYPE-2B BY PASSIVE-IMMUNIZATION WITH SEROTYPE-SPECIFIC MONOCLONAL-ANTIBODY [J].
BRODEUR, BR ;
LAROSE, Y ;
TSANG, P ;
HAMEL, J ;
ASHTON, F ;
RYAN, A .
INFECTION AND IMMUNITY, 1985, 50 (02) :510-516
[4]   VACCINES FOR PREVENTION OF MENINGOCOCCAL DISEASE [J].
FRASCH, CE .
CLINICAL MICROBIOLOGY REVIEWS, 1989, 2 :S134-S138
[5]  
Frasch CE, 1995, MENINGOCOCCAL DIS, P245
[6]   HUMAN IMMUNITY TO MENINGOCOCCUS .I. ROLE OF HUMORAL ANTIBODIES [J].
GOLDSCHNEIDER, I ;
GOTSCHLICH, EC ;
ARTENSTEIN, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (06) :1307-+
[7]   HUMAN IMMUNITY TO MENINGOCOCCUS .2. DEVELOPMENT OF NATURAL IMMUNITY [J].
GOLDSCHNEIDER, I ;
GOTSCHLICH, EC ;
ARTENSTEIN, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (06) :1327-+
[8]   HUMAN IMMUNITY TO MENINGOCOCCUS .4. IMMUNOGENICITY OF GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDES IN HUMAN VOLUNTEERS [J].
GOTSCHLICH, EC ;
GOLDSCHNEIDER, I ;
ARTENSTEIN, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (06) :1367-+
[9]  
GRIFFISS JM, 1983, J IMMUNOL, V130, P2882
[10]   A MONOCLONAL-ANTIBODY DIRECTED AGAINST A SEROTYPE-SPECIFIC, OUTER-MEMBRANE PROTEIN OF HAEMOPHILUS-INFLUENZAE TYPE-B [J].
HAMEL, J ;
BRODEUR, BR ;
LAROSE, Y ;
TSANG, PS ;
BELMAAZA, A ;
MONTPLAISIR, S .
JOURNAL OF MEDICAL MICROBIOLOGY, 1987, 23 (02) :163-170